Cerebral Venous Sinus Thrombosis Following Oral Contraceptive Use: A Review of Published Cases

Authors

  • Ahlberg O Department of Neurology, Karolinska Institute, Stockholm, Sweden Author
  • Matic I Department of Haematology, University of Zagreb, Zagreb, Croatia Author
  • Iliev V Department of Neuroradiology, Medical University of Plovdiv, Plovdiv, Bulgaria Author

DOI:

https://doi.org/10.5281/zenodo.22279343

Keywords:

Cerebral venous sinus thrombosis, Oral contraceptives, Thrombophilia, Anticoagulation, Venous thromboembolism

Abstract

Graphical abstract

Background: Cerebral venous sinus thrombosis (CVST) is an uncommon but potentially devastating stroke subtype affecting
young women, and oral contraceptive (OCP) use is its most frequent reversible risk factor. Objective: To review published case reports/series of OCP-associated CVST alongside the epidemiologic, pathophysiologic, diagnostic, and management literature.
Methods: Narrative review of case reports, case-control and cohort studies, meta-analyses, and guidelines. Findings: CVST incidence is roughly 1.3 per 100,000 person-years, higher in reproductive-age women; OCP use confers a pooled odds ratio near 7-10, rising with inherited thrombophilia (prothrombin G20210A, Factor V Leiden). Published cases span isolated headache to fulminant, fatal disease, occasionally complicated by subdural hematoma or dural arteriovenous fistula. MRV/CTV is diagnostic; D-dimer has limited negative predictive value. Anticoagulation is first-line, with thrombectomy and decompressive craniectomy for refractory or malignant courses.
Conclusions: Prognosis is generally favorable with prompt anticoagulation and OCP discontinuation; guidelines support
progestin-only or non-hormonal contraception thereafter.

References

Coutinho, J.M., Zuurbier, S.M., Aramideh, M., Stam, J. (2012) The Incidence of Cerebral Venous Thrombosis: A Cross-Sectional Study. Stroke, 43(12): 3375-3377.

Coutinho, J.M., Ferro, J.M., Canhão, P., Barinagarrementeria, F., Cantú, C., Bousser, M.G., Stam, J. (2009) Cerebral Venous and Sinus Thrombosis in Women. Stroke, 40(7): 2356-2361.

Martinelli, I., Sacchi, E., Landi, G., Taioli, E., Duca, F., Mannucci, P.M. (1998) High Risk of Cerebral-Vein Thrombosis in Carriers of a Prothrombin-Gene Mutation and in Users of Oral Contraceptives. New England Journal of Medicine, 338(25): 1793-1797.

de Bruijn, S.F., Stam, J., Koopman, M.M., Vandenbroucke, J.P. (1998) Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users who are carriers of hereditary prothrombotic conditions. BMJ, 316(7131): 589-592.

Amri, S.F., Alsudairy, N.M. (2025) Oral Contraceptive-Induced Cerebral Venous Thrombosis: A Case Report. Cureus, 17(2): e78407.

Amoozegar, F., Ronksley, P.E., Sauve, R., Menon, B.K. (2015) Hormonal Contraceptives and Cerebral Venous Thrombosis Risk: A Systematic Review and Meta-Analysis. Frontiers in Neurology, 6: 7.

Dentali, F., Crowther, M., Ageno, W. (2006) Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood, 107(7): 2766-2773.

Abbattista, M., Truma, A., Martinelli, I., Gianniello, F., Passamonti, S.M., Artoni, A., et al. (2025) The risk of cerebral vein thrombosis associated with different types of combined hormonal contraceptives: a case-control study. Journal of Thrombosis and Haemostasis, 23(9): 3263-3271.

Hannaford, P.C. (2011) Epidemiology of the contraceptive pill and venous thromboembolism. Thrombosis Research, 127(Suppl 3): S30-S34.

Moeindarbari, S., Beheshtian, N., Hashemi, S. (2022) Cerebral vein thrombosis in a woman using oral contraceptive pills for a short period of time: a case report. Journal of Medical Case Reports, 16: 260.

Sheerani, M., Urfy, M.Z.S. (2006) Oral contraceptives and cerebral venous thrombosis: case report and a brief review of literature. Journal of the Pakistan Medical Association, 56(11): 559-561.

Vandenbroucke, J.P., Koster, T., Briet, E., Reitsma, P.H., Bertina, R.M., Rosendaal, F.R. (1994) Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. The Lancet, 344(8935): 1453-1457.

Kilavuz Suman, K., Goksedef, B.P., Koc, B. (2013) Cerebral venous sinus thrombosis in a healthy woman taking oral contraceptive: a case report and review of literature. Journal of the Turkish German Gynecological Association, 14(2): 110-113.

Practice Committee of the American Society for Reproductive Medicine (2016) Combined hormonal contraception and the risk of venous thromboembolism: a guideline. Fertility and Sterility, 107(1): 43-51.

Huang, Q., Chai, X., Xiao, C., Cao, X. (2019) A case report of oral contraceptive misuse induced cerebral venous sinus thrombosis and dural arteriovenous fistula. Medicine (Baltimore), 98(32): e16440.

Arrighi, M., et al. (2024) Unmasking hidden risks: cerebral venous sinus thrombosis and spontaneous subdural hematoma in women on oral contraceptives - insights from a case report and systematic literature review. Neurochirurgie, 70(6): 101613.

Uemura, M., Tsukamoto, Y., Akaiwa, Y., Watanabe, M., Tazawa, A., Kasahara, S., et al. (2016) Cerebral venous sinus thrombosis due to oral contraceptive use: postmortem 3 T-MRI and autopsy findings. Human Pathology: Case Reports, 6: 32-36.

Galarza, M., Gazzeri, R. (2009) Cerebral venous sinus thrombosis associated with oral contraceptives: the case for neurosurgery. Neurosurgical Focus, 27(5): E5.

Saposnik, G., Bushnell, C., Coutinho, J.M., Field, T.S., Furie, K.L., Galadanci, N., et al. (2024) Diagnosis and Management of Cerebral Venous Thrombosis: A Scientific Statement From the American Heart Association. Stroke, 55(3): e77-e90.

Ferro, J.M., Bousser, M.G., Canhão, P., Coutinho, J.M., Crassard, I., Dentali, F., et al. (2017) European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology. European Journal of Neurology, 24(10): 1203-1213.

Dentali, F., Squizzato, A., Marchesi, C., Bonzini, M., Ferro, J.M., Ageno, W. (2012) D-dimer testing in the diagnosis of cerebral vein thrombosis: a systematic review and a meta-analysis of the literature. Journal of Thrombosis and Haemostasis, 10(4): 582-589.

Ferro, J.M., Coutinho, J.M., Dentali, F., Kobayashi, A., Alasheev, A., Canhão, P., et al. (2019) Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial. JAMA Neurology, 76(12): 1457-1465.

Siddiqui, F.M., Dandapat, S., Banerjee, C., Zuurbier, S.M., Johnson, M., Stam, J., Coutinho, J.M. (2015) Mechanical thrombectomy in cerebral venous thrombosis: systematic review of 185 cases. Stroke, 46(5): 1263-1268.

Avanali, R., Gopalakrishnan, M.S., Devi, B.I., Bhat, D.I., Shukla, D.P., Shanbhag, N.C. (2019) Role of Decompressive Craniectomy in the Management of Cerebral Venous Sinus Thrombosis. Frontiers in Neurology, 10: 511.

Soriano-Navarro, E., et al. (2020) Bilateral Decompressive Craniectomy in Malignant Cerebral Venous Thrombosis. European Journal of Case Reports in Internal Medicine, 7(11): 001560.

Ferro, J.M., Canhão, P., Stam, J., Bousser, M.G., Barinagarrementeria, F.; ISCVT Investigators (2004) Prognosis of Cerebral Vein and Dural Sinus Thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke, 35(3): 664-670.

Le Moigne, E., Tromeur, C., Delluc, A., et al. (2016) Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study. Haematologica, 101: e12-e14.

Graphical abstract

Published

2025-09-17

Issue

Section

Articles

How to Cite

Cerebral Venous Sinus Thrombosis Following Oral Contraceptive Use: A Review of Published Cases. (2025). Archives of Clinical Case Reports, 8(1), 38-45. https://doi.org/10.5281/zenodo.22279343